Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer

Mise à jour : Il y a 4 ans
Référence : NCT01272791

Femme et Homme

Extrait

The primary objective of this study is to compare the overall survival of patients with stage IV pancreatic cancer treated with gemcitabine alone or gemcitabine with bavituximab.


Critère d'inclusion

  • Metastatic Pancreatic Cancer

Liens